Mark Stolper Sells 10,000 Shares of RadNet, Inc. (RDNT) Stock
RadNet, Inc. (NASDAQ:RDNT) VP Mark Stolper sold 10,000 shares of the stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $10.19, for a total transaction of $101,900.00. Following the sale, the vice president now owns 145,319 shares of the company’s stock, valued at approximately $1,480,800.61. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
RadNet, Inc. (RDNT) opened at 10.25 on Friday. The firm has a market capitalization of $484.48 million, a PE ratio of 53.95 and a beta of 1.01. The firm’s 50-day moving average is $8.33 and its 200-day moving average is $7.01. RadNet, Inc. has a 12 month low of $5.25 and a 12 month high of $10.77.
RadNet (NASDAQ:RDNT) last announced its earnings results on Tuesday, August 8th. The medical research company reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.07. The firm had revenue of $230 million during the quarter, compared to analysts’ expectations of $230.32 million. RadNet had a return on equity of 19.98% and a net margin of 1.04%. The company’s revenue was up 5.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.09 earnings per share. On average, equities research analysts expect that RadNet, Inc. will post $0.29 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: “Mark Stolper Sells 10,000 Shares of RadNet, Inc. (RDNT) Stock” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.thecerbatgem.com/2017/09/01/mark-stolper-sells-10000-shares-of-radnet-inc-rdnt-stock.html.
Several large investors have recently bought and sold shares of RDNT. Globeflex Capital L P raised its position in shares of RadNet by 15.7% in the first quarter. Globeflex Capital L P now owns 138,705 shares of the medical research company’s stock worth $818,000 after buying an additional 18,800 shares during the last quarter. Geode Capital Management LLC raised its position in RadNet by 6.6% in the first quarter. Geode Capital Management LLC now owns 274,192 shares of the medical research company’s stock valued at $1,617,000 after buying an additional 16,924 shares in the last quarter. Vanguard Group Inc. raised its position in RadNet by 2.5% in the first quarter. Vanguard Group Inc. now owns 1,233,623 shares of the medical research company’s stock valued at $7,278,000 after buying an additional 30,054 shares in the last quarter. Robotti Robert raised its position in RadNet by 0.8% in the first quarter. Robotti Robert now owns 748,416 shares of the medical research company’s stock valued at $4,416,000 after buying an additional 6,100 shares in the last quarter. Finally, Royce & Associates LP bought a new position in RadNet during the first quarter valued at about $118,000. 48.81% of the stock is owned by institutional investors.
Several analysts have recently commented on RDNT shares. BidaskClub upgraded shares of RadNet from a “buy” rating to a “strong-buy” rating in a research note on Thursday, August 24th. Jefferies Group LLC upgraded shares of RadNet from a “hold” rating to a “buy” rating and increased their price target for the company from $7.00 to $12.00 in a report on Tuesday, August 22nd. Zacks Investment Research upgraded shares of RadNet from a “sell” rating to a “hold” rating in a report on Wednesday, May 17th. Finally, TheStreet upgraded shares of RadNet from a “c” rating to a “b-” rating in a report on Thursday, August 24th. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $9.42.
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Stock Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related stocks with our FREE daily email newsletter.